ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,688, issued on Oct. 14, was assigned to KING SAUD UNIVERSITY (Riyadh, Saudi Arabia).

"CCR5 inhibitor" was invented by Fuad Ameen Saad Hasan (Riyadh, Saudi Arabia), Purnachandra Nagaraju Ganji (Riyadh, Saudi Arabia), Estari Mamidala (Riyadh, Saudi Arabia) and Abeer AbdulMoati AlMasri (Riyadh, Saudi Arabia).

According to the abstract* released by the U.S. Patent & Trademark Office: "A 4-(4-((4-(5-isopropyl-3-methyl-1H-pyrazole-4-carbonyl)-1,4-diazepan-1-yl)methyl)phenoxy)benzonitrile compound having a structure of formula I:"

The patent was filed on Jan. 30, 2025, under Application No. 19/041,219.

*For further information, including images, charts and tables, please visit: http:/...